🟢 Neurosense Therapeutics is trading 11.30% up today after August 20 selloff

Neurosense Therapeutics is trading 11.30% up at $0.39 after rebounding from its August 20 close of $0.35.

• Shares fell 11.96% on August 20.
• No new company-specific announcement dated August 21, 2026 was identified.
• Recent selling followed disclosed Phase 3 PARAGON ALS financing delays and Nasdaq compliance concerns, including a potential 1-for-4 to 1-for-40 reverse split. Today’s gain appears to be a trading rebound, not a confirmed fresh catalyst.